Ostrum Asset Management’s Gilead Sciences GILD Stock Holding History

Ostrum Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Sell	8,030 -18,466	-70%	-$2.59M	0.06%	210
2025 Q4	$3.25M	Sell	26,496 -7,077	-21%	-$860K	0.16%	99
2025 Q3	$3.73M	Buy	33,573 +5,099	+18%	+$580K	0.17%	109
2025 Q2	$3.16M	Sell	28,474 -6,879	-19%	-$732K	0.15%	127
2025 Q1	$3.96M	Sell	35,353 -777	-2%	-$80.2K	0.21%	89
2024 Q4	$3.34M	Sell	36,130 -10,934	-23%	-$984K	0.29%	89
2024 Q3	$3.95M	Sell	47,064 -17,275	-27%	-$1.32M	0.33%	72
2024 Q2	$4.41M	Sell	64,339 -10,193	-14%	-$680K	0.39%	53
2024 Q1	$5.46M	Sell	74,532 -1,326	-2%	-$102K	0.43%	41
2023 Q4	$6.15M	Buy	75,858 +10,627	+16%	+$827K	0.53%	31
2023 Q3	$4.89M	Sell	65,231 -12,679	-16%	-$975K	0.45%	44
2023 Q2	$6M	Sell	77,910 -7,875	-9%	-$628K	0.5%	36
2023 Q1	$7.12M	Buy	+85,785	New	+$7.11M	0.62%	17
2019 Q1	–	Sell	-11,945	Closed	-$747K	–	148
2018 Q4	$747K	Buy	+11,945	New	+$835K	0.29%	104

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ostrum Asset Management's GILD Position: Q1 2026 in Review

Ostrum Asset Management reduced its Gilead Sciences (GILD) stake by 70% in Q1 2026, selling an estimated $2.59M and leaving 8,030 shares worth $1.12M. The position accounts for 0.06% of the portfolio, ranked #210.

Ostrum Asset Management first reported a position in GILD in Q4 2018 and has held it in 14 quarters since. The position peaked at $7.12M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Ostrum Asset Management held 8,030 shares of Gilead Sciences worth $1.12M as of Q1 2026.
Ostrum Asset Management sold 18,466 Gilead Sciences shares in Q1 2026, an estimated $2.59M.
Gilead Sciences made up 0.06% of Ostrum Asset Management's portfolio in Q1 2026, its #210 holding.
Ostrum Asset Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 14 quarters since.
Ostrum Asset Management's Gilead Sciences position peaked at $7.12M in Q1 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.